000 | 02205 a2200589 4500 | ||
---|---|---|---|
005 | 20250516172430.0 | ||
264 | 0 | _c20150413 | |
008 | 201504s 0 0 eng d | ||
022 | _a1941-2703 | ||
024 | 7 |
_a10.1089/jamp.2013.1040 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDaley-Yates, Peter T | |
245 | 0 | 0 |
_aPharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients. _h[electronic resource] |
260 |
_bJournal of aerosol medicine and pulmonary drug delivery _cAug 2014 |
||
300 |
_a279-89 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 |
_aAdrenergic beta-2 Receptor Agonists _xadministration & dosage |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAerosols |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlbuterol _xadministration & dosage |
650 | 0 | 4 |
_aAndrostadienes _xadministration & dosage |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 |
_aAsthma _xdiagnosis |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aDry Powder Inhalers |
650 | 0 | 4 | _aEquipment Design |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluticasone-Salmeterol Drug Combination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNew South Wales |
650 | 0 | 4 | _aNew Zealand |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 | _aPowders |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aMehta, Rashmi | |
700 | 1 | _aChan, Robert H | |
700 | 1 | _aDespa, Simona X | |
700 | 1 | _aLouey, Margaret D | |
773 | 0 |
_tJournal of aerosol medicine and pulmonary drug delivery _gvol. 27 _gno. 4 _gp. 279-89 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/jamp.2013.1040 _zAvailable from publisher's website |
999 |
_c23124271 _d23124271 |